Inventor
LIBERMAN ANITA
IL20 patents
Patents
20 patentsUS6495721B1Dec 17, 2002
Sertraline hydrochloride Form II and methods for the preparation thereof
TEVA PHARMA58 citations96
US6500987B1Dec 31, 2002
Sertraline hydrochloride polymorphs
TEVA PHARMA38 citations95
US6600073B1Jul 29, 2003
Methods for preparation of sertraline hydrochloride polymorphs
TEVA PHARMA14 citations92
US6909004B2Jun 21, 2005
Method for the purification of lansoprazole
TEVA PHARMA5 citations73
US7196222B2Mar 27, 2007
Sertraline hydrochloride form II and methods for the preparation thereof
TEVA PHARMA1 citations62
US7060837B2Jun 13, 2006
Method for the purification of lansoprazole
TEVA PHARMA3 citations62
US7022881B2Apr 4, 2006
Sertraline hydrochloride polymorphs
TEVA PHARMA3 citations62
US7022859B2Apr 4, 2006
Method for the purification of lansoprazole
TEVA PHARMA2 citations62
US6576764B2Jun 10, 2003
Synthesis and crystallization of piperazine ring-containing compounds
TEVA PHARMA2 citations62
US6545149B2Apr 8, 2003
Synthesis and crystallization of piperazine ring-containing compounds
TEVA PHARMA3 citations62
US6723855B2Apr 20, 2004
Method for synthesizing leflunomide
TEVA PHARMA4 citations61
US7534900B2May 19, 2009
Process for the purification of duloxetine hydrochloride
TEVA PHARMA3 citations60
US7319171B2Jan 15, 2008
Sertraline hydrochloride form II and methods for the preparation thereof
TEVA PHARMA0 citations52
US7683080B2Mar 23, 2010
Stable iansoprazole containing more than 500 ppm, up to about 3,000 ppm water and more than 200 ppm, up to about 5,000 ppm alcohol
TEVA PHARMA0 citations51
US7678816B2Mar 16, 2010
Method of stabilizing lansoprazole
TEVA PHARMA0 citations51
US7622588B2Nov 24, 2009
Method for the purification of lansoprazole
TEVA PHARMA0 citations51
US7399871B2Jul 15, 2008
Crystal forms of (S)-(+)-N,N-dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine oxalate and the preparation thereof
TEVA PHARMA1 citations51
US7842717B2Nov 30, 2010
DNT-maleate and methods of preparation thereof
TEVA PHARMA0 citations50
US7683177B2Mar 23, 2010
Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazole
TEVA PHARMA0 citations50
US7759500B2Jul 20, 2010
2-(N-methyl-propanamine)-3-(2-naphthol)thiophene, an impurity of duloxetine hydrochloride
TEVA PHARMA0 citations41